Viohalco S.A. (0QI2)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 15.06 |
|---|---|
| 52-week range | 8.05 – 23.20 |
| Return, 1 month / 3 months | −11.3% / −13.8% |
| Return, 1 year / 3 years | +86.9% / +218.5% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 48.6% |
| Worst drawdown (1 year) | -32.9% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Viohalco is a holding company for a group of metals processing and manufacturing businesses based in Belgium, with operations centred on Greece. Its subsidiaries make steel and aluminium products, copper and brass products, and cables, serving customers in construction, energy, transportation and general industry. The group supplies fabricated metal goods and semi-finished materials to industrial and trade customers across Europe and beyond, coordinating the activities of its individual operating companies.
On this site Viohalco S.A. appears as a stock on the London Exchange (UK), code 0QI2, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Viohalco S.A. (0QI2) trades on the London Exchange in UK. It last closed at EUR 15.06 on 23 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,765 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 86.9% and over the last three months it fell 13.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.9% | ||
| From 52-week high | -32.9% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -13.8% | ||
| 6-month return | 7.6% | ||
| 12-month return, skipping the last month | 110.7% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.9% | ||
| Liquidity | 8 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 16 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −5.8% |
|---|---|
| 1 month | −11.3% |
| 3 months | −13.8% |
| 6 months | +7.6% |
| 1 year | +86.9% |
| 3 years | +218.5% |
| 5 years | +258.8% |
Signals
| 50-day / 200-day average | 16.75 / 16.17 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jun 2026 | EUR 0.1890 |
| 24 Jun 2025 | EUR 0.1120 |
| 19 Jun 2023 | EUR 0.0840 |
| 3 Jun 2022 | EUR 0.0630 |
| 28 May 2021 | EUR 0.0210 |
| 7 Sep 2020 | EUR 0.0070 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.